Protagonist Therapeutics, Inc.

NasdaqGM:PTGX Stock Report

Market Cap: US$3.2b

Protagonist Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:PTGX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Apr 25SellUS$80,776Asif AliIndividual1,756US$46.00
19 Feb 25SellUS$204,607Dinesh PatelIndividual5,359US$38.18
26 Nov 24SellUS$4,600,875Dinesh PatelIndividual98,273US$46.96
15 Nov 24SellUS$78,108Arturo MolinaIndividual1,906US$40.98
11 Sep 24SellUS$98,232Asif AliIndividual2,203US$44.59

Insider Trading Volume

Insider Buying: PTGX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of PTGX?
Owner TypeNumber of SharesOwnership Percentage
State or Government26,4850.0396%
Individual Insiders689,5081.03%
VC/PE Firms3,250,0004.86%
Hedge Funds11,826,42117.7%
Institutions51,148,70276.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
BlackRock, Inc.
9,736,719US$497.2m-1.5%0.01%
9.85%
Farallon Capital Management, L.L.C.
6,107,006US$311.8m2.98%1.73%
9.23%
RTW Investments, LP
5,719,415US$292.0m4.02%4.03%
6.9%
The Vanguard Group, Inc.
4,277,218US$218.4m1.35%no data
5.24%
Deep Track Capital, LP
3,250,000US$165.9m8.33%5.33%
4.37%
State Street Global Advisors, Inc.
2,706,619US$138.2m-18.8%no data
4.15%
BVF Partners L.P.
2,575,015US$131.5m35.5%4.69%
3.95%
Johnson & Johnson Innovation - JJDC, Inc.
2,449,183US$125.1m0%36.6%
2.3%
Geode Capital Management, LLC
1,423,559US$72.7m3.38%no data
2.13%
T. Rowe Price Group, Inc.
1,322,006US$67.5m-5.07%0.01%
1.76%
Perceptive Advisors LLC
1,091,271US$55.7m-14.2%1.89%
1.59%
Wellington Management Group LLP
987,370US$50.4m5.03%0.01%
1.52%
ADAR1 Capital Management, LLC
939,669US$48.0m-7.91%8.29%
1.45%
Woodline Partners LP
897,699US$45.8m54.2%0.27%
1.18%
Lynx1 Capital Management LP
733,014US$37.4m0%10.78%
1.11%
American Century Investment Management Inc
685,824US$35.0m-26.1%0.02%
1.07%
Invesco Capital Management LLC
664,570US$33.9m12%0.01%
1.03%
Northern Trust Global Investments
639,507US$32.7m1.74%no data
1.02%
Jefferies Financial Group Inc.,Asset Management Arm
631,893US$32.3m-57.6%0.48%
0.91%
UBS Asset Management AG
561,627US$28.7m33.6%no data
0.9%
Charles Schwab Investment Management, Inc.
557,718US$28.5m-3.58%no data
0.88%
Eversept Partners, L.P.
547,116US$27.9m-19.4%2.9%
0.81%
683 Capital Management, LLC
500,000US$25.5m22%2.37%
0.77%
FMR LLC
478,280US$24.4m8.12%no data
0.74%
Goldman Sachs Group, Investment Banking and Securities Investments
461,642US$23.6m-22.4%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/04 21:18
End of Day Share Price 2025/06/04 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Protagonist Therapeutics, Inc. is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas TsaoBarclays
Mayur SomaiyaBMO Capital Markets Equity Research
Etzer DaroutBMO Capital Markets Equity Research